ADHD: Current Concepts and Future Developments Program

Course Description

Ongoing clinical and scientific advances have transformed the field of ADHD. Substantial knowledge has been gained on the neuropathology, neurobiology, heritability, environmental, persistence, comorbidity, psychotherapeutic and pharmacological treatment of ADHD in children, adolescents and adults. This CME-accredited course will feature nationally renowned ADHD faculty who will educate participants on recent research findings relevant to clinical practice.

Who Should Attend
This unique day-and-a-half course is designed for child and adult psychiatrists, pediatricians, family practitioners, and other allied mental health experts working to improve the quality of care for patients with ADHD across the continuum of care.

Educational Objectives

The educational goal of this program is to increase professional specialists’ awareness of the clinical course and treatment of adolescent and adult patients with ADHD. At the conclusion of this educational activity, participants should be able to:

• Be more familiar with the presentation, diagnosis, co-morbidity, and current treatment options available for individuals with ADHD
• Utilize the ASRS Self-Report Screener and Symptom Checklist for the identification of adult patients with ADHD
• Identify the ongoing challenges to identification and management of ADHD in adults with and without co-morbid disorders, such as substance use and mood disorders

Course Directors

Betsy Busch, MD, FAAP

Tufts University

Richard Rubin, MD

Vermont Clinical Study Center

Dartmouth Medical College

Course Faculty and Topics

Lenard Adler, MD

Diagnosis and Assessment of ADHD

Scott Kollins, PhD

ADHD, Nicotine and Smoking

Jeffrey Newcorn, MD

Neuroimaging and ADHD Treatment

Anthony Rostain, MD

Integrating Cognitive Behavior Therapy and Medical Treatments

Richard Rubin, MD

Recent Combined ADHD and Anxiety Clinical Research

Mark Stein, PhD

Pharmacogenetics of ADHD

Timothy Wilens, MD

Comorbidity of ADHD with Substance Abuse

Mark Wolraich, MD

Treatment of Adolescent ADHD with Stimulants

Financial Support
This educational activity is supported by an independent medical educational grant from Lilly USA, LLC, and Shire.

CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 10.0 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Its CE programs are developed in accordance with the “Criteria for Quality and Interpretive Guidelines” of the ACPE. This program is acceptable for 10.0 contact hours of Continuing Education Credit. Universal Program Number: 827-000-09-237-L01-P Disease State Management/Drug Therapy. Knowledge-based CPE activity.

NURSING CREDIT
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 10.0 contact hour(s). Program Number: 09-237-229

APA CREDIT
This program is co-sponsored by the Philadelphia Society of Clinical Psychologists and MediCom Worldwide, Inc. The Philadelphia Society of Clinical Psychologists is approved by the American Psychological Association to sponsor Continuing Education for psychologists.  The Philadelphia Society of Clinical Psychologists maintains responsibility for the program and its content.  This program provides 10 hours of CE credits for Psychologists.

Disclosure
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. 
 
Conflict of Interest Resolution
MediCom Worldwide, Inc. has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. When individuals in a position to control content have reported financial relationships with one or more commercial interests, MediCom Worldwide, Inc. works with them to resolve such conflicts to ensure that the content presented is free of commercial bias.

Americans with Disabilities Act/Special Needs
MediCom Worldwide, Inc. is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veterans status, or sexual orientation.

Conference Fees

Special – Save $50 on a one year membership AND meeting registration

 

Membership Fee:…………. $175

Registration Fee:

Members………………   $400

Non-Members…………   $600

Physicians in Training...    $200
New Member & Meeting Registration……$525

All participants must complete the Activity Evaluation Form. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates will be mailed 6 to 8 weeks following the program.

Hotel Information
A special reduced room rate at the Philadelphia Marriott Downtown for meeting participants is $159 single/double, plus prevailing taxes. Please be sure that apsapsa is entered as the group code.  Alternatively, you can call Marriott at 215-625-2900 and mention that you are with the APSARD meeting. Room reservations will be confirmed on a first come, first served basis, based on availability until Sunday, October 25, 2009.  Reservation requests received after the cut-off date will be based on availability at the hotel’s prevailing rate.